ARTICLE | Company News
Genetic Technologies, Nanogen deal
April 22, 2002 7:00 AM UTC
NGEN received a non-exclusive license to GTG's intron sequence patents for use in genetic research and human diagnostics. GTG will receive AUS$620,000 ($331,600) in NGEN stock and cash. ...